Japan has one of the most developed biotechnology sectors in the world, as evidenced by the high number of patents filed. Although the number of bio venture start-ups peaked in 2006, several foreign firms are now trying to enter the market. Moreover, the government is supporting the sector’s development and has passed several laws to assist it; it is being viewed as a national strategy. Find out more about Japan's biotechnology sector below.
Japan has one of the most developed biotechnology sectors in the world, as evidenced by the high number of patents filed. The number of bio venture start-ups peaked in 2013 and several foreign firms are now trying to enter the market.
As Asia’s largest bioinformatics database is based in Japan, this is an important and competitive sector for the country. In particular, the application of bioinformatics to the pharmaceutical industry is the subject of significant R&D in Japan.
Japan is the third largest pharmaceuticals market in the world. As a result of the country's ageing population, there is a continuous increase in societal healthcare awareness.
Japan remains one of the world’s largest per-capita importers of food and feed produced using modern biotechnologies.
This website and related activities are managed by the EU-Japan Centre for Industrial Cooperation, a joint venture between the European Commission's Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs (DG GROW) and the Japanese Government's Ministry of Economy, Trade & Industry (METI).
